Literature DB >> 638677

Reversal of clofibrate-induced cholesterol oversaturation of bile with chenodeoxycholic acid.

M C Bateson, P E Ross, J Murison, I A Bouchier.   

Abstract

Giving clofibrate 2 g daily to seven patients significantly increased the biliary cholesterol concentration while the proportion of bile acids fell. Five patients on established clofibrate treatment were given 750 mg of chenodeoxycholic acid (CDCA) daily for one month. Biliary lipid analysis after the CDCA treatment showed a significant fall in the proportion of cholesterol and a rise in that of bile acids. The serum lipid concentrations, which had already been reduced by diet and clofibrate, showed a further significant reduction after the introduction of CDCA. This study suggests that CDCA may be usefully combined with clofibrate to reverse the tendency towards cholesterol saturation of bile and enhance the effect of lowering serum lipid concentrations.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 638677      PMCID: PMC1604263          DOI: 10.1136/bmj.1.6121.1171

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  12 in total

1.  Effect of polyunsaturated and saturated fatty acids on the cholesterol holding capacity of human bile.

Authors:  N WATANABE; N S GIMBEL; C G JOHNSTON
Journal:  Arch Surg       Date:  1962-07

2.  Effect of different doses of chenodeoxycholic acid on bile-lipid composition and on frequency of side-effects in patients with gallstones.

Authors:  H Y Mok; G D Bell; R H Dowling
Journal:  Lancet       Date:  1974-08-03       Impact factor: 79.321

3.  Effects of clofibrate and of an estrogen-progestin combination on fasting biliary lipids and cholic acid kinetics in man.

Authors:  D Pertsemlidis; D Panveliwalla; E H Ahrens
Journal:  Gastroenterology       Date:  1974-04       Impact factor: 22.682

4.  Letter: A simple calculation of the lithogenic index of bile: expressing biliary lipid composition on rectangular coordinates.

Authors:  P J Thomas; A F Hofmann
Journal:  Gastroenterology       Date:  1973-10       Impact factor: 22.682

5.  The effect of clofibrate on the elimination of cholesterol as bile acids in patients with hyperlipoproteinaemia type II and IV.

Authors:  K Einarsson; K Hellström; M Kallner
Journal:  Eur J Clin Invest       Date:  1973-07       Impact factor: 4.686

6.  Cholesterol production in obesity.

Authors:  T A Miettinen
Journal:  Circulation       Date:  1971-11       Impact factor: 29.690

7.  Letter: Clofibrate and gallstones.

Authors:  J Cooper; H Geizerova; M F Oliver
Journal:  Lancet       Date:  1975-05-10       Impact factor: 79.321

8.  Effects of obesity and caloric intake on biliary lipid metabolism in man.

Authors:  L J Bennion; S M Grundy
Journal:  J Clin Invest       Date:  1975-10       Impact factor: 14.808

9.  Effect of prolonged feeding with chenodeoxycholic acid on bile in patients with and without gallstones.

Authors:  M C Bateson; P E Ross; J Murison; I A Bouchier
Journal:  Gut       Date:  1977-08       Impact factor: 23.059

10.  Cholesterol solubility in bile. Evidence that supersaturated bile is frequent in healthy man.

Authors:  R T Holzbach; M Marsh; M Olszewski; K Holan
Journal:  J Clin Invest       Date:  1973-06       Impact factor: 14.808

View more
  3 in total

1.  Hypocholesterolemic activity of racemic dichlorophenoxypropionic acid or its enantiomers in rats.

Authors:  F Ohta; F Gaudemer; C Lutton
Journal:  Bull Environ Contam Toxicol       Date:  1987-12       Impact factor: 2.151

2.  [Relation between serum lipoprotein metabolism and biliary lipid metabolism].

Authors:  O Leiss; K von Bergmann
Journal:  Klin Wochenschr       Date:  1983-06-15

Review 3.  Chenodeoxycholic acid: a review of its pharmacological properties and therapeutic use.

Authors:  J H Iser; A Sali
Journal:  Drugs       Date:  1981-02       Impact factor: 9.546

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.